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ORIGINAL ARTICLE
Tuberculosis screening in patients with HIV: use of audit
and feedback to improve quality of care in Ghana
Stephanie Bjerrum1,2*, Frank Bonsu3, Nii Nortey Hanson-Nortey3,
Ernest Kenu4,5, Isik Somuncu Johansen1, Aase Bengaard Andersen2,6,
Lars Bjerrum7, Dorte Jarbøl8 and Anders Munck8
1Department of Infectious Diseases, Odense University Hospital, Odense, Denmark; 2Institute of Clinical
Research, Faculty of Health Sciences, University of Southern Denmark, Odense, Denmark; 3National
Tuberculosis Control Programme, Disease Control and Prevention Department, Ghana Health Services,
Korle-Bu Teaching Hospital, Accra, Ghana; 4Department of MedicineFevers Unit, Korle-Bu Teaching
Hospital, Accra, Ghana; 5School of Public Health, University of Ghana, Legon, Accra, Ghana; 6Department of
Infectious Diseases, Copenhagen University Hospital, Rigshospitalet, Copenhagen, Denmark; 7Department
of Public Health, University of Copenhagen, Copenhagen, Denmark; 8Department of Public Health,
University of Southern Denmark, Odense, Denmark
Background: Tuberculosis screening of people living with HIV (PLHIV) can contribute to early tuberculosis
diagnosis and improved patient outcomes. Evidence-based guidelines for tuberculosis screening are available,
but literature assessing their implementation and the quality of clinical practice is scarce.
Objectives: To assess tuberculosis screening practices and the effectiveness of audit and performance feedback
to improve quality of tuberculosis screening at HIV care clinics in Ghana.
Design: Healthcare providers at 10 large HIV care clinics prospectively registered patient consultations during
May and October 2014, before and after a performance feedback intervention in August 2014. The outcomes
of interest were overall tuberculosis suspicion rate during consultations and provider adherence to the
International Standards for Tuberculosis Care and the World Health Organizations’ guidelines for symptom-
based tuberculosis screening among PLHIV.
Results: Twenty-one healthcare providers registered a total of 2,666 consultations; 1,368 consultations before
and 1,298 consultations after the feedback intervention. Tuberculosis suspicion rate during consultation
increased from 12.6 to 20.9% after feedback (odds ratio, OR 1.83; 95% confidence interval, CI: 1.093.09).
Before feedback, sputum smear microscopy was requested for 58.7% of patients with suspected tuberculosis,
for 47.2% of patients with cough ]2 weeks, and for 27.5% of patients with a positive World Health
Organization (WHO) symptom screen (any of current cough, fever, weight loss or night sweats). After
feedback, patients with a positive WHO symptom screen were more likely to be suspected of tuberculosis
(OR 2.21; 95% CI: 1.194.09) and referred for microscopy (OR 2.71; 95% CI: 1.255.86).
Conclusions: A simple prospective audit tool identified flaws in clinical practices for tuberculosis screening of
PLHIV. There was no systematic identification of people with suspected active tuberculosis. We found low
initial tuberculosis suspicion rate compounded by low referral rates of relevant patients for sputum smear
microscopy. Adherence to recommended standards and guidelines for tuberculosis screening improved after
performance feedback.
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Introduction
Tuberculosis remains a leading cause of morbidity and
mortality among people living with HIV (PLHIV) (1). A
review of post-mortem studies among HIV-infected
individuals showed that tuberculosis was implicated in
33% of all HIV-associated adult deaths in sub-Saharan
Africa, with almost half of the fatal cases undiagnosed
in life (2). In Ghana, the HIV epidemic is moderate with
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a prevalence of 1.4% (3). The overall tuberculosis
prevalence is 282/100,000 (4), and low tuberculosis case
detection rate overall and among PLHIV has been
identified as main challenges in the country (5).
To increase tuberculosis case detection among PLHIV
in resource-constrained areas, great effort has been made
to evaluate tuberculosis screening algorithms and diag-
nostic tests (68). In 2011, the World Health Organiza-
tion (WHO) endorsed a four-symptom-based clinical
algorithm as part of their guidelines for tuberculosis
screening of PLHIV (9). Moreover, The International
Standards for Tuberculosis Care (ISTC) published by
WHO and the American Thoracic Society is available to
promote high-quality services (10, 11). However, there is
little information on the quality of tuberculosis screening
practices in the context of routine care. To date, studies
have focused on coverage of tuberculosis screening based
on retrospective record reviews or routine health infor-
mation (1215). These studies reported great variation in
coverage with a general increase over time and after
education of healthcare providers. Low referral rates for
tuberculosis diagnostic test were reported in some of the
studies (13, 15). Still, the need remains to assess
healthcare providers’ initial tuberculosis suspicion and
decision to refer patients for further diagnostic tests as
well as identify strategies to improve quality of care under
real-life conditions.
Clinical audit and feedback is a tool to assess clinical
practice and improve the quality of care, and has been
found effective to close the gap between routine practice
and recommended guidelines (16, 17). Audit has pre-
viously been used to assess the quality of diagnosis of
smear-negative pulmonary tuberculosis (18) and to im-
prove general tuberculosis diagnostic services in Latin
America (19). In collaboration with the National Tuber-
culosis Control Programme (NTP) in Ghana, we con-
ducted a quality improvement study at 10 large HIV care
clinics. The aim was to assess healthcare providers’
adherence to widely recommended standards for HIV-
associated tuberculosis screening and evaluate if audit
and feedback could improve performance. We used a
simple tool for audit and feedback based on prospective
self-registration of healthcare providers’ clinical practice
focusing on tuberculosis suspicion and referral for
sputum smear microscopy. We use the Standards for
Quality Improvement Reporting Excellence (SQUIRE
2.0) to report our results (20).
Methods
Design
This is a prospective study with a one-group pre- and
post-evaluation of audit and feedback to address and
improve the quality of tuberculosis screening practices at
HIV care clinics.
Study sites and context
The study was conducted at 10 large HIV care clinics
located in major hospitals from three regions in the
southern zone of Ghana. The clinics were selected from
the national list of public HIV care clinics based on the
following criteria: 3,000 PLHIV enrolled at the clinics;
access to X-ray and sputum smear microscopy for acid-
fast bacilli at the hospital premises; and availability of a
tuberculosis care clinic or a clinic with integrated delivery
of HIV and tuberculosis services at the hospital premises.
Two of the HIV care clinics were affiliated to a major
teaching hospital. Half of the study sites had access to a
specific clinic with integrated HIV/tuberculosis services at
the hospital.
In Ghana, the NTP and the National AIDS Control
Programme (NACP) implement HIV and tuberculosis
collaborative services and perform routine monitoring and
supporttohealthfacilities.Asinmanyresource-constrained
areas, sputum smear microscopy is the most widely used
tuberculosisdiagnostictest,whilenewdiagnostictestlikethe
XpertMTB-RIFisbeingscaledup(21).Nationalguidelines
recommend regular symptom-based tuberculosis screening
of PLHIV including questions on cough and duration (]2
weeks or B2 weeks), cough with blood, weight loss, night
sweats, fever, chest pain, and history of any contact to
persons known with tuberculosis (22, 23). All individuals
with cough]2 weeks should be referred for sputum smear
microscopy for acid-fast bacilli. The WHO guidelines
available for tuberculosis screening in PLHIV recommend
that individuals reporting any weight loss, fever, night
sweats, and current cough (of any duration) should be
referred for further tuberculosis investigations (9). Accord-
ing to the WHO guidelines, isoniazid preventive treatment
(IPT) should be offered to those individuals reporting none
ofthesesymptoms,butIPTisnotyetimplementedinGhana.
At the time the study was conducted, 4 of 10 HIV care
clinics had access to Xpert MTB/RIF, but none used
Xpert MTB/RIF as part of routine diagnostic services for
tuberculosis.
Participants
We invited all healthcare providers involved in tubercu-
losis screening at the 10 HIV care clinics to participate in
the study. Medical doctors and nurses, but also physician
assistants and disease control officers, were invited for
participation if active in tuberculosis screening. Partici-
pants were asked to register consultations with PLHIV
during May and October 2014.
Data collection  Audit Project Odense
We used the Audit Project Odense (APO) method for
audit and compilation of feedback. The method is
originally developed for quality improvement in general
practice but has since been used widely (2427). The
APO method is based on prospective self-registration
of clinical practice during patient consultations using
Stephanie Bjerrum et al.
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a simple paper form. The form used for this study
(Supplementary material A) was designed for registra-
tions to take B2 min per consultation. The healthcare
providers were asked to register the first 15 consultations
with PLHIV daily for 24 weeks before and after a
feedback intervention  in the following referred to as the
first and second audit, respectively. Data registered
during consultation included demographic characteristics
of patients (age and sex); the consultation type (initial
assessment of a newly diagnosed HIV-infected individual
vs. follow-up consultations); antiretroviral treatment (ART)
status of patients (currently receiving ART, defaulted
ART for more than 1 month since last consultation, or
never received ART); tuberculosis-related signs and
symptoms presented during consultation (cough, weight
loss, night sweats, fever); the healthcare providers’ main
suspicion or diagnosis (including tuberculosis, pneumo-
nia, upper respiratory tract infection); and prescribed
investigations. Healthcare providers were carefully in-
structed orally and in writing (Supplementary material B)
on how to fill in the registration form before the first
audit and received a follow-up visit by the research team
during registration. They were further asked to complete
a form with background information about themselves
and the HIV care clinic they represented.
Feedback
Based on the results of the first audit, performance
feedback was developed for each of the healthcare
providers. This included a feedback report where the
results from the first audit were summarized in words,
tables, and diagrams focusing on the healthcare provi-
ders’ overall practice for suspecting tuberculosis and
referral of tuberculosis suspects for further investigations
(Fig. 1). Moreover, a personal feedback sheet was
developed for each participant to enable the individual
participant to compare their own results with those of
their peers. The feedback report and personal feedback
sheet were distributed to the healthcare providers prior to
a one-day feedback workshop held in August 2015. Here,
the feedback report was presented and discussed. The
findings were put in context with preliminary results from
the national tuberculosis prevalence survey, relevant
studies on the area, and the available guidelines for
tuberculosis screening. The workshop further comprised
group work sessions to identify challenges for adherence
to guidelines and possible areas for quality improvements.
The principal investigator (SB), a consultant for the APO
method (LB), and key persons from the NTP (FB and
NNHN) and NACP facilitated the feedback workshop.
Study outcome measures and definitions
The primary outcome measure was to determine and
characterize healthcare providers’ tuberculosis suspicion
rate. We defined a series of secondary outcome measures
based on recommended standards for tuberculosis screening
of PLHIV and adherence rates to these (Box 1). The
performance standards were selected in collaboration with
key informants at NTP and NACP and were based on the
ISTC and WHO guidelines (9, 10). A positive WHO
tuberculosis symptom screen (‘WHO-TB’) is defined
as PLHIV presenting with any of the following four
symptoms: fever, cough (of any duration, i.e. both the
variable cough B2 weeks and cough ]2 weeks), night
sweat, or weight loss (9).
Statistical analysis
Descriptive analysis was used to characterize the participat-
ing healthcare providers and the study population using chi-
square test for categorical variables and Wilcoxon rank-sum
for continuous variables. We used logistic regression models
with robust standards errors (SE) to obtain point estimates
for the outcome measures with 95% confidence intervals
(CI) pre- and post-feedback. As feedback targeted the
healthcare providers and not the HIV care clinic, we
adjusted for clustering of registrations by the same provider.
Difference in outcome measures was analysed for statistical
significance using logistic regression with results from the
first audit used as reference. Statistical significance was
defined as a two-sided p-value less than 0.05, and all
analyses were conducted using the statistical software
package STATATM (version 13.1).
Ethical clearance
The project was approved by the Ghana Health Service
Ethical Review Committee (GHS-ERC: 09/03/14), the
Ethical and Protocol Review Committee, University of
Ghana Medical School (MS-Et./M.4P 3.3/2012-13) and
evaluated by the Developing Country Committee of the
Danish National Committee on Health Research Ethics
(No. 1302133/1206169). The healthcare providers signed
a written informed consent form before participation. We
did not register any patient identifiable information apart
from age and sex nor expose patients to any intervention,Fig. 1. Feedback report.
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and hence, there were no requirements to collect in-
formed consent from patients contributing data.
Results
Healthcare providers’ details
Healthcare providers (n22) from 10 HIV care clinics
participated in the study including 10 medical doctors,
eight nurses, three physician assistants, and one disease
control officer. Registrations from one physician assistant
were excluded from analysis, since the person failed to
register according to instructions. The healthcare provi-
ders reported a medium of 5 years (IQR 210) of
expertise in a HIV care clinic and had a median of 40
(3070) outpatient consultations per day. All providers
received feedback and participated in the feedback
workshop; 16 providers participated in both audits.
Consultations
Data from 2,666 consultations with PLHIV were in-
cluded in the study based on registration of 1,368
consultations in the first audit and 1,298 consultations
in the second audit after performance feedback (Table 1).
Overall, consultations comprised of 2,185 (81.9%) follow-
up visits and 439 (16.5%) initial assessments of new HIV-
positive patients. The majority of patients consulted were
females 1,910 (71.6%) and most were receiving ART
1,869 (70.1%). Baseline variables differed between the two
audits with regard to consultation type, sex of the
individuals, proportion of patients that had defaulted
ART, and patients presenting with weight loss or cough
B2 weeks. After adjusting for clustering to healthcare
provider, only the sex of the patients remained signifi-
cantly different between the audits.
Tuberculosis suspicion rate
In the first audit, tuberculosis was suspected in 172/1,368
(12.6%) consultations with rates varying from 0.535.7%
across the healthcare providers. The tuberculosis suspi-
cion rate was higher in consultations with new HIV-
positive patients than at follow-up (28.4% vs. 9.9%, odds
ratio, OR 3.60; 95% CI: 2.335.55). Moreover, patients
not receiving ART and patients who had defaulted ART
for more than 1 month were more likely to be suspected
of tuberculosis than patients receiving ART. Patients
aged above 55 years were less likely to be suspected for
tuberculosis. The tuberculosis suspicion rate appeared
substantially lower for doctor-led consultations than for
consultations led by the other staff categories combined,
but the difference was borderline significant when
accounting for clustering (15.5% vs. 9.5% OR 1.75; 95%
CI: 0.993.11) (Table 2).
In the second audit, tuberculosis was suspected in 271/
1,298 (20.9%) consultations. Tuberculosis suspicion rates
were higher in consultation with patients of male sex,
patients newly diagnosed with HIV, patients not receiving
ART, or patients who defaulted ART. Patients in the age
groups 3555 years and above were less likely to be
suspected of tuberculosis than patients aged 1834 years,
although borderline significant for the age group above
55 years (Table 2).
The increase in tuberculosis suspicion rate from 12.6 to
20.9% after feedback was significant (OR 1.83; 95% CI:
1.093.09) (Fig. 2).
Adherence to standards for tuberculosis screening
and referral for sputum smear microscopy
The first audit highlighted wide gaps between practices of
tuberculosis screening and applicable performance stan-
dards. The healthcare providers suspected tuberculosis in
87/144 (60.4%) patients presenting with cough ]2 weeks
Box 1. Outcome measures compared to recommendations
Primary outcome measure
Tuberculosis suspicion rate
Secondary outcome measures Recommended standards
Proportion of individuals with cough ]2 weeks
suspected of tuberculosis
ISTC, Standard 1: All persons with otherwise unexplained cough lasting 23
weeks or more should be evaluated for tuberculosisa
Proportion of individuals with cough ]2 weeks referred
for sputum smear microscopy
Proportion of individuals who are suspected of
tuberculosis referred for sputum smear microscopy
ISTC, Standard 2: All patients (adults, adolescents, and children who are
capable of producing sputum) suspected of having pulmonary tuberculosis
should have at least two, and preferably three, sputum specimens obtained
for microscopic examinationa
Proportion of individuals with a positive WHO-TB screen
suspected of TB
Proportion of individuals with a positive WHO-TB screen
referred for sputum smear microscopy
WHO: Adults and adolescents living with HIV and screened for TB with a
clinical algorithm and who report any one of the symptoms of current cough,
fever, weight loss, or night sweats may have active TB and should be
evaluated for TB and other diseasesb
aInternational Standards for Tuberculosis Care, 2006 (10).
bWHO guidelines for tuberculosis screening among PLHIV, 2011 (9).
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and in 166/444 (37.4%) patients with a positive WHO-TB
screen. Sputum smear microscopy was requested for 101/
172 (58.7%) patients suspected of tuberculosis, for 68/144
(47.2%) patients presenting with cough ]2 weeks, and
for 122/444 (27.5%) patients with a positive WHO-TB
screen (Fig. 2).
In the second audit, providers’ tuberculosis suspicion
rate increased from 60.4 to 73.4% in patients presenting
with cough ]2 weeks and from 37.4 to 56.9% in patients
with a positive WHO-TB screen. The increase in tuber-
culosis suspicion rate was statistically significant for
patients with a positive WHO-TB screen (OR 2.21; 95%
CI: 1.194.09), but not for those with cough ]2 weeks
(OR 1.81; 95% CI: 0.754.36). Referral for sputum smear
microscopy increased to 74.9% in patients suspected of
tuberculosis, to 57.8% in patients presenting with cough
]2 weeks, and to 50.7% in patients with a positive
WHO-TB screen. The increase was significant in referral
of patients with a positive WHO-TB screen (OR 2.71;
95% CI: 1.255.86), but not for the other groups.
Discussion
In this study, a simple tool for audit and feedback was
integrated into the daily work of healthcare providers at
10 large HIV care clinics in Ghana. The first audit
identified low tuberculosis suspicion rates and a marked
gap between current practices and widely recommended
standards for tuberculosis screening. After feedback to
healthcare providers, we observed increased tuberculosis
suspicion rates and improved the quality of tuberculosis
screening performance. To our knowledge, this is the first
study to prospectively evaluate real-life practices for
tuberculosis screening at multiple HIV care clinics.
We found that providers’ initial tuberculosis suspicion
rate was only 12.6% in the first audit. We consider this to
be low, especially in the context of the high tuberculosis
prevalence in Ghana (4) and the high rates of HIV/
tuberculosis co-infections observed in resource-limited
settings (28). The prevalence of tuberculosis among
PLHIV in Ghana is not systematically described, but
we have recently reported a culture-confirmed tubercu-
losis prevalence of 12.7% among PLHIV eligible for ART
from a large teaching hospital in Ghana (29). In this
study, tuberculosis suspicion rate was highest in con-
sultation with the younger and newly diagnosed HIV-
positive patients. Tuberculosis suspicion rate was very
low for patients receiving ART (9%) and at follow-up
consultations (10%), although PLHIV remain at risk of
Table 1. Consultation and patient characteristics at first and second audit
Overall (N2,666) First audit (N1,368) Second audit (N1,298)
n (%) n % n %
Consultation
Initial 439 (16.5) 201 14.7 238 18.3
Follow-up 2,185 (81.9) 1,140 83.3 1,045 80.5
Unknown 42 (1.6) 27 2.0 15 1.2
Sex
Male 741 (27.8) 418 30.6 323 24.9
Female 1,910 (71.6) 943 68.9 967 74.5
Unknown 15 (0.6) 7 0.5 8 0.6
Age in years
Median (IQR) 40 (3348) 41 (3348) 40 (3348)
HIV Treatment status
Receiving ART 1,869 (70.1) 940 68.7 929 71.6
ART naive 580 (21.8) 291 21.3 289 22.2
Defaulted ART (1 month) 78 (2.9) 51 3.7 27 2.1
Unknown 139 (5.2) 86 6.3 53 4.1
Signs and symptoms
Weight loss 374 (14.0) 167 12.2 207 16.0
Fever 397 (14.9) 199 14.6 198 15.3
Cough B2 weeks 337 (12.6) 146 10.7 191 14.7
Cough ]2 weeks 298 (11.2) 144 10.5 154 11.9
Night sweats 172 (6.5) 80 5.9 92 7.1
Positive WHO-TB screena 908 (34.1) 444 32.5 464 35.8
ART, antiretroviral therapy.
aPositive WHO symptoms screen if presence of any of the following symptoms: current cough, fever, weight loss, or night sweat (9).
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tuberculosis throughout the course of HIV disease also
after initiating ART (3032).
Our study showed that healthcare providers deviate
from recommended guidelines and standards, despite
these being evidence-based. Providers did not consistently
suspect tuberculosis in patients presenting with cough
]2 weeks and less so in patients with any of the four
symptoms included in the WHO tuberculosis symptom
screen. While prolonged cough previously has been
identified as the most common symptom screened for
in relation to HIV-associated tuberculosis (14), the more
broadly defined WHO-TB symptoms seem less well
recognised by the healthcare providers as predictive for
tuberculosis.
Healthcare providers failed to refer a large proportion
of patients suspected of tuberculosis for sputum smear
microscopy. Other studies have also recognised low
referral rates for tuberculosis diagnostic tests as a ‘leaky’
step in the tuberculosis diagnostic cascade (13, 15).
Further down the diagnostic cascade, additional leaky
steps have been identified including low rates for comple-
tion of the tuberculosis diagnostic tests (33, 34) and high
rates of individuals that never start treatment despite a
positive test (35). Screening guidelines encourage that any
individual with a positive WHO-TB screen, including
individuals with cough ]2 weeks, should be referred for
further diagnostic tests regardless of whether the health
provider suspects tuberculosis (9). We found very low
referral rates for patients with a positive WHO-TB screen
(27.5%). This could reflect that the WHO-TB screening
algorithm is less well integrated at HIV care sites for
intensified tuberculosis case finding. Healthcare providers
may be reluctant to overburden the often already chal-
lenged tuberculosis laboratories. In our study, more than
one-third (34.1%) of the patients presented with a positive
WHO-TB screen. In studies of HIV-infected individuals
eligible to start ART, up to 90% had a positive WHO-TB
screen (36, 37) and the consequence of referring all for
sputum microscopy could be dire for a fragile health
system. The WHO’s TB-screening guideline favours a high
negative predictive value to identify those individuals,
unlikely to have tuberculosis (i.e. none of the four
symptoms reported) where IPT could be started to prevent
tuberculosis (7, 9). IPT to PLHIV is not programmatically
implemented in Ghana, and this may further contribute to
low adherence to the WHO-TB-screening guidelines.
Major progress has been made in developing accurate
and rapid diagnostic tools like the Xpert† MTB/RIF
Table 2. Tuberculosis suspicion rate overall and by subgroups shown for the first and second audit
First audit Second audit
Proportion of TB suspects n/N % ORa 95% CI P n/N % ORa 95% CI P
Overall 172/1,368 12.6 271/1,298 20.9%
By staff category
Medical doctors 63/665 9.5 ref 65/411 15.8% ref
Non-doctors 109/703 15.5 1.75 0.99 3.11 0.054 206/887 23.2% 1.61 0.54 4.79 0.391
By consultation
Follow-up 113/1,140 9.9 ref 140/1,045 13.4% ref
Initial 57/201 28.4 3.60 2.33 5.55 B0.001 128/238 53.8% 7.52 3.94 14.34 B0.001
By patient sex
Male 60/418 14.4 ref 84/323 26.0% ref
Female 111/943 11.8 0.80 0.54 1.18 0.251 186/967 19.2% 0.68 0.52 0.88 0.004
By age (years)
017 10/45 22.2 1.51 0.56 4.06 0.416 5/25 20.0% 0.66 0.23 1.87 0.433
1834.9 57/358 15.9 ref 92/335 27.5% ref
3554.9 87/794 11.0 0.65 0.39 1.07 0.093 146/768 19.0% 0.62 0.39 0.99 0.044
]55 17/170 10.0 0.59 0.38 0.92 0.020 27/167 16.2% 0.51 0.25 1.06 0.069
By ART status
Receiving ART 87/940 9.3 ref 113/929 12.2% ref
ART naive 58/291 19.9 2.44 1.47 4.05 0.001 123/289 42.6% 5.35 3.09 9.27 B0.001
Defaulted ART (1 month) 14/51 27.5 3.71 1.72 8.02 0.001 15/27 55.6% 9.03 3.14 25.91 B0.001
ART, antiretroviral treatment.
aOR: Odds ratio adjusted for clustering of registrations within health provider.
Non-doctors includes nurses (n8), physician assistants (n2), and disease control officer (n1).
Missing values excluded from analysis; sex (n15), age (n4), consultation (n42), ART status (n139).
P-values in bold indicate values B0.05.
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(Cepheid, USA). However, implementation of diagnostic
tools like the Xpert MTB/RIF has not yet been able to
demonstrate reduced mortality in randomised control
trials in Africa, despite the great potentials of the test (38,
39). The trials emphasised that the impact of even the
most promising tuberculosis diagnostic test is compro-
mised if not coupled to good standards of clinical
care (40). The first steps for tuberculosis screening to
be effective, regardless of the test, are that healthcare
providers suspect tuberculosis in individuals with relevant
signs and symptoms and refer them for further diagnostic
tests. In our study, inadequate tuberculosis suspicion and
low referral rates for sputum microscopy represent low
standards of HIV care and a missed opportunity for
tuberculosis case detection. We observed that tuberculo-
sis suspicion rates among healthcare providers increased
and standards of care improved with audit and feedback.
However, we noted a heterogeneous tuberculosis suspi-
cion rate across healthcare providers, and whereas some
providers improved performance significantly after feed-
back, others did not change practice for tuberculosis
screening. Furthermore, there was a trend of higher
Cough >= 2 weeks
)484/
WHO-TB+
+/3/)1st audit missed opportunity 2nd audit missed opportunity
47.2%
57.8%
Cough >= 2 weeks
58.7%
74.9%
All TB suspects WHO-TB+
12.6%
20.9%
60.4%
73.4%
37.4%
59.6%
27.5%
50.7%
Overall
n=172 n=271 n=87 n=113 n=166 n=264
n=101 n=203 n=68 n=89 n=122 n=235
1st audit: N=144
2nd audit: N=154
OR: 1.81 (0.75–4.36)
1st audit: N=1,368
2nd audit: N=1,298
OR: 1.83* (1.09–3.09)
1st audit: N=444
2nd audit: N=464
OR: 2.21* (1.19–4.09)
1st audit: N=172
2nd audit: N=271
OR: 2.10 (0.75–5.86)
1st audit: N=444
2nd audit: N=464
OR: 2.71* (1.25–5.86)
1st audit: N=144
2nd audit: N=154
OR: 1.53 (0.69–3.40)
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Fig. 2. Tuberculosis suspicion rate and adherence to standards for tuberculosis screening and referral for sputum smear
microscopy.
(a) Tuberculosis suspicion rate among healthcare providers at first audit and second audit.
(b) Referral rate for sputum smear microscopy among healthcare providers at first audit and second audit.
Percentages are given as n/N.
OR: Odds ratio shown with results from audit 1 as reference, adjusted for clustering of registrations within the health provider.
WHO-TB: Positive WHO symptoms screen defined as presence of any of the following symptoms; current cough, fever,
weight loss or night sweats (9).
Missing values excluded from analysis; sex (n15), age (n4), consultation (n42), ART status (n139).
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tuberculosis suspicion among nurses than medical doc-
tors, although it levelled out in the second audit. More-
over, tuberculosis suspicion rate was significantly higher
in males in the second audit while not in the first audit,
and also in age groups, there was a shift in significant
differences. Feedback was, in our study, not tailored to
specific staff categories or site-specific barriers for
tuberculosis screening. It is possible that audit and
feedback, as part of a multi-faceted intervention with
targeted initiatives, could improve performance further
(16). The tool we used for audit and feedback was simple
and operational in the daily work of the healthcare
providers and effective to identify quality concerns in
provider practices. The same tool could be used to
monitor and ensure changes in practices after implemen-
tation of other interventions to improve tuberculosis case
finding. In Ghana, the NTP has recently modified the
algorithm for systematic tuberculosis screening of all
outpatient attendees. The audit and feedback tool
described here is currently being adapted for program-
matic implementation within the health system context
and challenges to evaluate the revised systematic tuber-
culosis screening of outpatients.
Our study has limitations. Healthcare providers had to
dedicate extra time to fill in the registration form after
consultation. In a setting with a high patient flow, this
might be difficult and may compromise participation in
the audit and quality of entries. Therefore, we instructed
the participants to register only the first 15 consultations
per day and limited the requirement for details so that
entries in the form took B2 minutes. We did not include
patient identifiable information and could, therefore, not
ascertain if the same patient was entered several times.
However, we aimed to characterize the consultation
practices rather than the patients. Furthermore, we did
not have the capacity to follow up on patients to report
the actual test results for patients referred and cannot
provide information on the rates for completing a test or
starting treatment for tuberculosis given a positive test.
Another limitation is that participants may have
registered what they perceived as the correct practice
rather than what truly happened. This could have been
avoided by direct observation of practices that was out of
scope for this study. The design of our study prevents us
to draw causal inferences, and other factors than the
audit and intervention could be responsible for the
change seen in performance. Some of the changes
observed could be related to concurrent activities to
increase tuberculosis case detection or may reflect the
increased focus on tuberculosis screening aroused by the
national prevalence survey. In future studies, it could be
beneficial to include a control group or a qualitative
assessment of contextual factors that could have affected
the changes in performance observed in our study.
Conclusion
A simple audit tool for quality development identified a
low tuberculosis suspicion rate and substandard perfor-
mance of healthcare providers’ tuberculosis screening
practices at HIV care clinics in Ghana. Performance
improved after audit and feedback to the healthcare
providers, in particular for adherence to the WHO
guidelines for tuberculosis screening of PLHIV. Flaws
in healthcare provider practices for tuberculosis screening
and referral for sputum smear microscopy at this level
represent a lost opportunity for tuberculosis case detec-
tion and inadequate HIV care. To harvest the full benefit
of new promising diagnostic technologies, the practices of
healthcare providers must come more into focus and
effort must be placed on identifying and closing gaps in
the quality of clinical care.
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Paper context
The success of improved tuberculosis diagnostic test relies on
healthcare providers’ practices and adherence to evidence-
based tuberculosis screening guidelines. We found low
tuberculosis suspicion rates among healthcare providers at
HIV care clinics in Ghana compounded by low referral rates
for sputum smear microscopy. Adherence to guidelines
improved with audit and feedback. Our study proposes a
simple method of prospective audit and feedback to quantify
substandard performance and improve the quality of clinical
practices for tuberculosis screening.
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